CBD / Hemp

FDA Commissioner Dr Scott Gottlieb, MD, testified before Congress on Wednesday.  Photo courtesy of FDA.

Gottlieb: FDA plans meeting in April on new CBD regulations

By Hank Schultz

FDA Commissioner Dr. Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. The goal is to create “an appropriately efficient and predictable regulatory framework for regulating CBD products,”...

© Getty Images / MysteryShot

Virun forms CBD specialist division

By Hank Schultz

Contract manufacturing and formulation specialist Virun has launched a division devoted solely to CBD formulations. An executive said this was in response to overwhelming interest in the market.

© Getty Images / ThamKC

Special Edition: Supplements for Pets

Where is the innovation in the pet supplements space?

By Stephen Daniells

Delivery systems and proprietary ingredients are the tip of the innovation spear for pet supplements (think cats and dogs), but nothing is hotter than one ingredient: CBD.

Getty Images

The big issues for 2019: CBD, the microbiome and more

By Stephen Daniells, Hank Schultz and Adi Menayang

The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five of our Top 10 big issues that will impact the dietary supplements industry in 2019.

NPA CEO on CBD: ‘Folks need to take the front door with FDA’

NOTES FROM SUPPLYSIDE WEST 2018

NPA CEO on CBD: ‘Folks need to take the front door with FDA’

By Stephen Daniells

The Natural Products Association’s stance on CBD is to take FDA’s word on the controversial ingredient, until someone takes the front door with the Agency and files an NDI or a GRAS notification with the FDA for CBD.

© Getty Images / Aleksandr_Kravtsov

Top FDA official: ‘Anyone who thinks CBD is lawful is mistaken’

By Stephen Daniells

“Just because we haven’t taken enforcement action people seem to think it [CBD] is OK,” said Steven Tave, director of the FDA’s Office of Dietary Supplement Programs, at a recent industry conference. “Anyone who thinks it is lawful is mistaken.”

Marketing CBD is mostly about risk tolerance, legal expert says

Marketing CBD is mostly about risk tolerance, legal expert says

By Hank Schultz

The source of CBD should be of concern for the companies marketing the ingredient, said a legal expert at a recent dietary supplement industry event. But he also said the regulatory landscape for the ingredient is shifting so fast that any opinions he...

© Getty Images / Aleksandr_Kravtsov

'Ignorance is amok... not even the investors are asking the right questions. It’s total anarchy'

SPECIAL FEATURE: What is the regulatory status of CBD in food and beverage products?

By Elaine Watson

If you ask the FDA or the DEA if CBD (cannabidiol) is permitted in foods, beverages and supplements, the answer is a pretty unequivocal NO. If you ask the scores of companies currently selling it in everything from CBD-infused soda to smoothie kits, the...

FDA says no to CBD in supplements

FDA says no to CBD in supplements

By Hank Schultz

In a recently updated communication on marijuana, the Food and Drug Administration has flatly stated that products based on cannabidiol (CBD), a non-narcotic fraction of Cannabis sativa, cannot be marketed as dietary supplements.  The reason? A pre-existing...

Follow us

Products

View more

Webinars